Detalhe da pesquisa
1.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 491-503, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272513
2.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med
; 386(21): 1973-1985, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403841
3.
Long-Term Survival and Recurrence Patterns in Locally Advanced Esophageal Squamous Cell Carcinoma Patients with Pathologic Complete Response After Neoadjuvant Chemotherapy Followed by Surgery.
Ann Surg Oncol
; 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172446
4.
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Future Oncol
; 19(8): 549-557, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815433
5.
Pre-operative oil ingestion reduces the probability of thoracic duct trunk ligation during esophagectomy.
Dis Esophagus
; 36(6)2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533426
6.
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
J Biol Chem
; 294(1): 327-340, 2019 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409900
7.
Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Cancer Sci
; 110(5): 1735-1745, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30844117
8.
ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
; 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366184
9.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Lancet Oncol
; 19(1): 139-148, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174310
10.
Factors to Consider in Surgical Resection of Pulmonary Metastatic Carcinoma.
Ann Surg Oncol
; 30(3): 1297-1298, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629991
11.
Discrimination of Malignant versus Benign Mediastinal Lymph Nodes Using Diffusion MRI with an IVIM Model.
Eur Radiol
; 28(3): 1301-1309, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929210
12.
P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma.
Dis Esophagus
; 30(2): 1-10, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868288
13.
Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database.
Ann Surg Oncol
; 23(2): 619-25, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474558
14.
CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy.
Ann Surg Oncol
; 22 Suppl 3: S1380-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940570
15.
The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.
J Surg Res
; 188(2): 442-50, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525058
16.
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
Signal Transduct Target Ther
; 8(1): 76, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823150
17.
Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.
Thorac Cancer
; 13(1): 137-140, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34866350
18.
Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma-A rare case report and comprehensive literature review.
Thorac Cancer
; 13(7): 1083-1087, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253375
19.
IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor.
Biology (Basel)
; 11(11)2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358276
20.
Feasibility of same-day discharge following endoscopic submucosal dissection for esophageal or gastric early cancer.
World J Gastroenterol
; 28(41): 5957-5967, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405109